Spots Global Cancer Trial Database for Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer

Official Title: Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer

Study ID: NCT01899989

Conditions

Non-small Cell Lung Cancer

Interventions

Stereotactic Body Radiation Therapy (SBRT)

cisplatin or carboplatin-based

Study Description

Brief Summary: The purpose of this study is to determine if the use of exploratory immunologic biomarkers, functional MRI images can serve as early predictors for response of NSCLC. It also will provide important information on the perceived side effects from a patient perspective. Patients may participate if they have tumors ≥3 cm without lymph node involvement (for which chemotherapy is not part of the standard of care). Patients will only receive stereotactic body radiation therapy (SBRT) per standard dose guidelines.

Detailed Description: